Liraglutide
Short-acting GLP-1 agonist (Victoza, Saxenda). Daily subcutaneous injection for weight loss and blood sugar control. Predecessor to semaglutide.
Calorize — peptide protocol & nutrition tracker
This substance is approved by regulators as a medicine and is dispensed on prescription. The dose is chosen by a doctor. The calculator below converts a dose you have already been prescribed into syringe units — it does not replace a prescription.
Approved by the FDA and EMA (Saxenda, Victoza). Prescription-only.
Every figure on this page is a dose reported in published sources. It is reference information, not a recommendation and not a protocol to follow. Any decision about injecting is one to make with a doctor.
Medical disclaimerWhat is Liraglutide?
Liraglutide is a GLP-1 receptor agonist, FDA-approved since 2010. Known under the brand names Victoza (for type 2 diabetes) and Saxenda (for weight loss). Unlike semaglutide, it has a short half-life (~13 hours) and is injected daily, not weekly.
What follows is dosing arithmetic and numeric protocols drawn from published sources and clinical trials. It describes what those sources report; it is not medical advice and not instructions for use. This part of the page is meant for people aged 18 and over.
The confirmation is kept in this browser, and on the account for signed-in users. The peptide description and its regulatory status are available without it.
What follows is dosing arithmetic and numeric protocols drawn from published sources and clinical trials. It describes what those sources report; it is not medical advice and not instructions for use. This part of the page is meant for people aged 18 and over.
The confirmation is kept in this browser, and on the account for signed-in users. The peptide description and its regulatory status are available without it.
Rapid weight loss burns muscle along with fat — that is what sits behind Ozempic face. Enough protein is what separates the two.
Check Protein Norm